Health
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
HANGZHOU and SHAOXING, China, Jan. 24, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces dosing of the first patient in Phase III clinical trial of ASC40 (Denifanstat) for treatment of moderate to severe acne vulgaris at Huashan Hospital, Fudan University. This P...
2024-01-24 16:50
2450
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints
EPALINGES, Switzerland and PARIS, Jan. 24, 2024 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative immunotherapies for cancer treatment, today announced that the phase 1 clinical trial of OT-A201 (Study No. A20101), a firs...
2024-01-24 15:00
1459
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide
* Oral ecnoglutide was safe and well tolerated with gastrointestinal side effects as the most commonly reported adverse events * Study participants receiving up to 30 mg oral ecnoglutide once-daily for 6 weeks achieved a mean body weight reduction of -6.8% from baseline, compared to -0.9% for...
2024-01-24 10:00
1704
INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness
Global landscape analysis identifies strengths and gaps in R&D pipeline to inform international pandemic preparedness efforts ROME and CAMBRIDGE, Mass., Jan. 24, 2024 /PRNewswire/ -- The INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating the devel...
2024-01-24 08:22
1447
IMG Mobile App Now Available with 24/7 Access to Coverage for All Customers
INDIANAPOLIS, Jan. 23, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is happy to announce its award-winning mobile app, IMG Mobile, is now available to all IMG customers. While previously available to select cu...
2024-01-23 22:00
1799
Stena Sessan AB requests compulsory buy-out and Concordia Maritime applies for delisting
GOTHENBURG, Sweden, Jan. 23, 2024 /PRNewswire/ -- Stena Sessan AB ('Stena Sessan'), which holds more than 90 per cent of the shares and votes in Concordia Maritime AB (publ) ('Concordia Maritime'), has requested that a compulsory buy-out of the remaining shares in Concordia Maritime be initiated....
2024-01-23 21:32
1752
Caliway Received First Approval of CBL-514 Pivotal Phase 3 Study Application for Subcutaneous Fat Reduction
NEW TAIPEI CITY, Jan. 23, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway's application to initiate CBL-514's Pivotal Phase 3 study (CBL-0301) for subcutaneous fat reduction. "We are all delighted to see CBL-514 showing its ...
2024-01-23 21:12
1698
Metabolon and Sheffield Institute for Translational Neuroscience Join Forces to Propel ALS Research and Biomarker Discovery
Collaboration aims to transform research to improve patient outcomes and enhance the understanding of ALS and motor neuron diseases (MND) MORRISVILLE, N.C., Jan. 23, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life scien...
2024-01-23 21:03
1509
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
* PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives inthe United States. * Amadix becomes the first European company to announce this recognition for early detection of colorectal...
2024-01-23 18:00
2150
Apollo Cancer Centres launches India's 1st AI-Precision Oncology Centre
BENGALURU, India, Jan. 23, 2024 /PRNewswire/ -- In a significant move that will
substantially enhance the quality of oncology care,Apollo Cancer Centre
2024-01-23 16:27
1599
2024 Japan Prize Laureates Announced
TOKYO, Jan. 23, 2024 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2024 Japan prize onJanuary 23, 2024. Prof. Sir Brian J. Hoskins (UK) and Prof.John Michael Wallace (USA) are co-winners of the Japan Prize in the fields of Resources, Energy, the Environment, and Social I...
2024-01-23 14:00
729
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis - Primary efficacy endpoints: * NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD A...
2024-01-23 12:17
2320
First Myeloma Patient Treated with CAR-T Successfully Discharged
SHANGHAI, Jan. 23, 2024 /PRNewswire/ -- In another milestone since the implementation of CAR-T therapy at Jiahui, the first myeloma patient treated with CAR-T at Jiahui International Hospital was recently discharged two weeks after infusion. The foreign patient was first diagnosed with multiple ...
2024-01-23 10:19
2076
Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.
HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut inthe United States. Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost expe...
2024-01-23 10:06
2576
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
GAITHERSBURG, Md., Jan. 23, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and ...
2024-01-23 06:00
2781
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2024) to be he...
2024-01-22 19:00
1598
Asia Research News provides a source-finding platform for journalists
A one-stop resource for expertise and science is now available. Get tip sheets for research stories fromAsia. CAMBRIDGE, England and PENANG, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Asia Research News, the unrivalled leader of scientific news and experts forAsia, is set to sail into its 20th yea...
2024-01-22 17:00
2094
KL Wellness City Drives Healthcare Tourism with IoT Integration
KUALA LUMPUR, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Since its grand launch in June 2023, KL Wellness City (KLWC) has been a trailblazer, reshaping integrated healthcare and wellness. This visionary city, housing the flagship KL International Hospital (KLIH) and The Nobel Healthcare Park, is set...
2024-01-22 12:50
2209
Guangdong on the Road | Angels that give sight in Fiji
GUANGZHOU, China, Jan. 22, 2024 /PRNewswire/ -- Through the "Guangdong on the Road" series, GDToday joins hands with global reporters and sheds light on Guangdong's partnership under the Belt and Road Initiative. 2023 marks the 60th anniversary of China dispatching its first Chinese medical te...
2024-01-22 10:35
2082
xTool's First-Ever Brand Safety Campaign Kicks Off with a Notable Trade-In Program
IRWINDALE, Calif., Jan. 22, 2024 /PRNewswire/ -- xTool
2024-01-22 10:00
1782
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685